Ask a question. Get a source-grounded answer with citations.
Based on 6 verified sources covering Thailand, Myanmar:
Kathua (Jammu and Kashmir) [India], January 9 (ANI): As many as 13000 youth are covered under Yuva Mission and Rs 750 crore is disbursed to start thier entrepreneurship. [1]
TOKYO -- Umami Bioworks, a Singapore-based seafood biotechnology startup, plans to establish a facility producing lab-grown seafood in Japan as early as 2027, at a cost of roughly 1.5 billion yen ($9.88 million). [2]
NEW DELHI -- Biocon Biologics, a subsidiary of Indian biotech giant Biocon, has secured board approval for an investment of $150 million from U.S.-based investment bank Goldman Sachs. [3]
NEW DELHI -- Biocon Biologics, a unit of India's largest biopharmaceutical company Biocon, is in talks with Asia-focused Baring Private Equity Asia to raise funding in lieu of a minority stake, sources familiar with the matter told DealStreetAsia. [4]
Mumbai (Maharashtra) [India], June 29 (ANI/NewsVoir): Bengaluru has seen a very high demand for commercial real estate with oversubscription to the latest property offering, reported MYRE Capital, India's first neo-realty investment platform and a ve... [5]
San Jose (California) [USA]/Pune (Maharashtra) [India], May 26 (ANI/PRNewswire): OptraSCAN®, the leading On-Demand Digital Pathology solution provider, today announced its intelligent solution CytoSiA for rapid yet affordable scanning and analyzing o... [6]
Kathua (Jammu and Kashmir) [India], January 9 (ANI): As many as 13000 youth are covered under Yuva Mission and Rs 750 crore is disbursed to start thier entrepreneurship.
TOKYO -- Umami Bioworks, a Singapore-based seafood biotechnology startup, plans to establish a facility producing lab-grown seafood in Japan as early as 2027, at a cost of roughly 1.5 billion yen ($9.88 million).
NEW DELHI -- Biocon Biologics, a subsidiary of Indian biotech giant Biocon, has secured board approval for an investment of $150 million from U.S.-based investment bank Goldman Sachs.
NEW DELHI -- Biocon Biologics, a unit of India's largest biopharmaceutical company Biocon, is in talks with Asia-focused Baring Private Equity Asia to raise funding in lieu of a minority stake, sources familiar with the matter told DealStreetAsia.
Mumbai (Maharashtra) [India], June 29 (ANI/NewsVoir): Bengaluru has seen a very high demand for commercial real estate with oversubscription to the latest property offering, reported MYRE Capital, India's first neo-realty investment platform and a ve
San Jose (California) [USA]/Pune (Maharashtra) [India], May 26 (ANI/PRNewswire): OptraSCAN®, the leading On-Demand Digital Pathology solution provider, today announced its intelligent solution CytoSiA for rapid yet affordable scanning and analyzing o